Annora Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANNORA PHARMA, and what generic and branded alternatives to ANNORA PHARMA drugs are available?
ANNORA PHARMA has forty-two approved drugs.
There are four tentative approvals on ANNORA PHARMA drugs.
Drugs and US Patents for Annora Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annora Pharma | MEXILETINE HYDROCHLORIDE | mexiletine hydrochloride | CAPSULE;ORAL | 216463-003 | Nov 9, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Annora Pharma | GABAPENTIN | gabapentin | SOLUTION;ORAL | 217682-001 | Jan 17, 2024 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Annora Pharma | IVABRADINE HYDROCHLORIDE | ivabradine hydrochloride | TABLET;ORAL | 213366-001 | Oct 5, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Annora Pharma | LURASIDONE HYDROCHLORIDE | lurasidone hydrochloride | TABLET;ORAL | 218174-001 | Aug 21, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Annora Pharma | DIVALPROEX SODIUM | divalproex sodium | TABLET, EXTENDED RELEASE;ORAL | 215527-002 | Sep 26, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Annora Pharma | OXCARBAZEPINE | oxcarbazepine | TABLET;ORAL | 215939-001 | Jan 11, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.